Volatility Premium Plus ETF (ZVOL)
Live price chart, market sentiment, and community perspectives for Volatility Premium Plus ETF (CBOE: ZVOL).
Live price chart, market sentiment, and community perspectives for Volatility Premium Plus ETF (CBOE: ZVOL).
On our desk, the narrative surrounding ZVOL is defined by its massive headline distribution rate nearing 70%. Retail and yield-chasing participants gravitate heavily toward the monthly income stream. However, institutional sentiment remains highly cautious due to the steep capital depreciation seen in the 1-year and 3-year performance metrics, proving that high distributions come at the direct expense of underlying NAV erosion.
When analyzing ZVOL for portfolio allocation protocols, we emphasize parsing the difference between its 30-day SEC yield of 0.94% and its staggering distribution rate of over 69%. The distribution relies heavily on option income and structural decay mechanics of VIX futures rather than fundamental earnings or organic interest, requiring strict hedging and exit criteria.
Reviewing the structural mechanics of the Volatility Premium Plus ETF, ZVOL targets daily investment results corresponding to the SandP 500 VIX Mid-Term Futures Inverse Daily Index. As a non-diversified fund with an expense ratio of 1.42% and total assets hovering around $13.67M, risk managers must treat it strictly as a tactical options-adjacent instrument rather than a core long-term holding.
Looking at the pricing data, ZVOL trades in a 52-week range between 7.82 and 13.02 with an average daily volume under 40,000 shares. The low liquidity profile and small market capitalization of roughly $15.2M mean that execution slippage can severely impact tactical rebalancing, making limit orders an absolute prerequisite.
Social sentiment trackers and financial message boards show polarized views on ZVOL. While yield enthusiasts praise the monthly cash flow consistency, seasoned macro analysts point out the severe 35.33% one-year loss and nearly 47.46% multi-year drawdown, categorizing the fund as a classic high-yield value trap for uninformed capital.
Explore plasma cleansing, somatic organ swaps, and BCI.